Isospec Analytics has raised $1.9M to develop new technologies for molecular analysis that can quickly identify unknown molecules, helping nutrition companies create safer products and enabling researchers to discover new biomarkers. The pre-seed round of $1.9M was led by Founderful (formerly Wingman Ventures), with additional investment from Tiny.vc, another.vc, and Venture Kick.
Identifying unknown molecules is crucial when developing new drugs, nutritional products, or pesticides, but the process is often lengthy and unsuccessful, leading to regulatory setbacks or potential health risks for consumers. Current methods for identifying unknown molecules primarily rely on mass analysis, which may not provide enough information. Isospec’s technology overcomes these limitations by generating unique, information-rich metrics that allow for rapid identification of unknown molecules in minutes, rather than months, revolutionizing molecular identification.
Isospec’s breakthrough technology, originating from the Laboratory of Molecular Physical Chemistry (LCPM) at EPFL, is already being used in the food and agritech industry to analyze sugars and metabolites for quality control and product R&D. By providing rapid and accurate identification of unknown molecules, Isospec’s technology brings scalability and efficiency to molecular analysis processes.